ArticleThe New England journal of medicine2003
Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.
Article in The New England journal of medicine, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- The effectiveness of vaginal progesterone in reducing preterm birth in high-risk patients diagnosed with short cervical length after 24 weeks: A retrospective cohort study.Frontiers in medicine · 2023Article
- 17-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study.American journal of obstetrics and gynecology · 2017Article
- Progestin treatment for the prevention of preterm birth.Acta obstetricia et gynecologica Scandinavica · 2011Review
- Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety.Therapeutics and clinical risk management · 2009Article
- Recurrent preterm birth.Seminars in perinatology · 2007Review
- Terbutaline increases the cervical resistance of the pregnant rat in vitro.Naunyn-Schmiedeberg's archives of pharmacology · 2005Article
- Functional effects of 17alpha-hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro.Reproductive biology and endocrinology : RB&E · 2004Article
Corrections and comments
- Comment on
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
12968095What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.